Complete remission with bortezomib on plasmocytomas in an end-stage patient with refractory multiple myeloma who failed all other therapies including hematopoietic stem cell transplantation: possible enhancement of graft-vs-tumor effect.
E
E
Paubelle
P
P
Coppo
L
L
Garderet
L
L
Azizi
D
D
Bories
N-C
NC
Gorin
L
L
Fouillard
D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D005500:Follow-Up Studies; D020544:Graft vs Leukemia Effect; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D010954:Plasmacytoma / Q000150:complications / Q000188:drug therapy*; D011719:Pyrazines / Q000627:therapeutic use*; D012074:Remission Induction; D014057:Tomography, X-Ray Computed; D017211:Treatment Failure; D016896:Treatment Outcome
D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib